Role, relevance and participation of all stakeholders in oncology (3/4)
11 Apr 2011
Role, relevance and participation of all stakeholders in oncology (3/4)
Advancing multidisciplinary cancer management (1/4)
Eribulin shows promise in phase-III trial
Improving patient compliance with treatment schedules
Acute myeloid leukaemia: the challenges
Benefits of maintenance therapy for multiple myeloma
Autologous stem cell transplants for multiple myeloma
Treatment of elderly MDS patients
Maintenance therapy for multiple myeloma
Treatment of elderly non-Hodgkin’s lymphoma patients
Main issues in treating elderly patients with myeloma
Use of comorbidities to determine CLL patient fitness